James T. Borello
UTHR icon

James T. Borello’s United Therapeutics UTHR Stock Holding History

James T. Borello’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$6.5K Hold
12
– – ﹤0.01% 716
2026
Q2 		$6.5K Hold
12
– – ﹤0.01% 715
2026
Q1 		$7.12K Hold
12
– – ﹤0.01% 666
2025
Q4 		$5.85K Buy
12
+8
+200% +$3.73K ﹤0.01% 535
2025
Q3 		$1.68K Buy
+4
New +$1.34K ﹤0.01% 753

Other funds holding UTHR

AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Seizert Capital Partners
Seizert Capital Partners Birmingham, Michigan $2.3B AUM 16.06% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Atwood & Palmer
Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
Achmea Investment Management
Achmea Investment Management Zeist, Netherlands $12.6B AUM 25.68% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

James T. Borello's UTHR Position: Q3 2026 in Review

James T. Borello held its United Therapeutics (UTHR) position steady in Q3 2026 at 12 shares worth $6.5K. The position accounts for ﹤0.01% of the portfolio, ranked #716.

James T. Borello first reported a position in UTHR in Q3 2025 and has held it in 5 quarters since. The position peaked at $7.12K in Q1 2026. 261 funds tracked by Wall St. Rank hold UTHR as of Q3 2026.

  • James T. Borello held 12 shares of United Therapeutics worth $6.5K as of Q3 2026.
  • James T. Borello left its United Therapeutics share count unchanged in Q3 2026.
  • United Therapeutics made up ﹤0.01% of James T. Borello's portfolio in Q3 2026, its #716 holding.
  • James T. Borello first reported a position in United Therapeutics in Q3 2025 and has held it in 5 quarters since.
  • James T. Borello's United Therapeutics position peaked at $7.12K in Q1 2026.
  • 261 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2026.

Based on James T. Borello's 13F filing for Q3 2026, filed 16 Oct 2026.